Alvares-Teodoro, J., Silva Mendes, A., Mesquita Camelo, R., Guerra JĂșnior, A., & Acurcio, F. (2025). Cost-effectiveness of gene therapy with etranacogene dezaparvovec versus factor IX prophylaxis in men with hemophilia B in Brazil. Medical Research Archives, 13(1). doi:10.18103/mra.v13i1.6167